CRSP Competitors & Alternatives
Compare Crispr Therapeutics AG with similar stocks in the same industry
Biotechnology
CRSP
Main Stock$53.99
Tradestie Score
59
Market Cap
$6.02B
Revenue Growth
0.7%
Analyst Upside
+54.7%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABVX
Abivax SA American Depositary Shares
|
$98.43
|
$6.38B | - | 54 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$29.30
|
$6.03B | - | 52 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.44
|
$5.95B | - | 60 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$241.97
|
$5.92B | - | 59 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.94
|
$5.80B | 19.0 | 57 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$340.21
|
$5.20B | 46.2 | 60 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$51.96
|
$4.94B | - | 60 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$82.13
|
$4.93B | - | 56 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$79.90
|
$4.84B | - | 62 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
More CRSP Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
227 stocks in this industry